As of 2019, the latest year for which data are available, more than 37 million people in the United States—or 11.3 percent of the country’s population—are living with diabetes, according to the U.S. Centers for Disease Control and Prevention. Among them, 8.5 million are adults who are undiagnosed or unaware that they have the condition. For those who require insulin, easy access is essential. However, problems such as shortages and unpredictable pricing can create significant obstacles.
A preliminary first-in-human study, to be presented at Digestive Disease Week 2023 on May 6–9, has found that a minimally invasive procedure may potentially eliminate the need for prescription insulin for a year in patients with type 2 diabetes.
